Compounds > 3,4-dihydroxyphenylacetic acid

3,4-dihydroxyphenylacetic acid and epidermal growth factor

3,4-dihydroxyphenylacetic acid has been researched along with epidermal growth factor in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's2 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Dalia, A; Fitkin, JG; Hadjiconstantinou, M; Neff, NH1
DiStefano, L; Schneider, JS1

Other Studies

2 other study(ies) available for 3,4-dihydroxyphenylacetic acid and epidermal growth factor

ArticleYear
Epidermal growth factor enhances striatal dopaminergic parameters in the 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-treated mouse.
    Journal of neurochemistry, 1991, Volume: 57, Issue:2

    Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; 3,4-Dihydroxyphenylacetic Acid; Animals; Cells, Cultured; Cerebral Ventricles; Corpus Striatum; Dopamine; Embryo, Mammalian; Epidermal Growth Factor; Infusions, Parenteral; Male; Mesencephalon; Mice; Reference Values; Tyrosine 3-Monooxygenase

1991
Enhanced restoration of striatal dopamine concentrations by combined GM1 ganglioside and neurotrophic factor treatments.
    Brain research, 1995, Mar-20, Volume: 674, Issue:2

    Topics: 3,4-Dihydroxyphenylacetic Acid; Animals; Dopamine; Epidermal Growth Factor; Fibroblast Growth Factor 2; G(M1) Ganglioside; Injections, Intraventricular; Male; Mice; Mice, Inbred C57BL; MPTP Poisoning; Neostriatum; Tyrosine 3-Monooxygenase

1995